Biology subjects

Dorel, M.

Publications and source records attributed to Dorel, M..

3 recordsLinked to original sources

bioRxiv2018

Modelling Signalling Networks from Perturbation Data

MotivationIntracellular signalling is realized by complex signalling networks which are almost impossible to understand without network models, especially if feedbacks are involved. Modular Response Analysis (MRA) is a convenient modelling method to study signalling networks in various contexts.\n\nResultsWe developed a derivative of MRA that is suited to model signalling networks from incomplete perturbation schemes and multi-perturbation data. We applied the method to study the effect of SHP2, a protein that has been implicated in resistance to targeted therapy in colon cancer, using data from a knock out and parental colon cancer cell line. We find that SHP2 is required for MAPK signalling, whereas AKT signalling only partially depends on SHP2.\n\nAvailabilityAn R-package is available at https://github.com/MathurinD/STASNet\n\nContactnils.bluethgen@charite.de

bioinformatics↗

bioRxiv2016

Dissecting cancer resistance to therapies with cell-type-specific dynamic logic models

Therapies targeting specific molecular processes, in particular kinases, are major strategies to treat cancer. Genomic features are commonly used as biomarkers for drug sensitivity, but our ability to stratify patients based on these features is still limited. As response to kinase inhibitors is a dynamic process affecting largely signal transduction, we investigated the association between cell-specific dynamic signaling pathways and drug sensitivity. We measured 14 phosphoproteins under 43 different perturbed conditions (combination of 5 stimuli and 7 inhibitors) for 14 colorectal cancer cell-lines, and built cell-line-specific dynamic logic models of the underlying signaling network. Model parameters, representing pathway dynamics, were used as features to predict sensitivity to a panel of 27 drugs. This analysis revealed associations between cell-specific signaling pathways and drug sensitivity for 14 of the drugs, 9 of which have no genomic biomarker. Following one of these associations, we validated a drug combination predicted to overcome resistance to MEK inhibitors by co-blockade of GSK3. These results underscore the value of perturbation-based studies to find biomarkers and combination therapies complementing those based on a static genomic characterization.

cancer biology↗

bioRxiv2016

NaviCom: A web application to create interactive molecular network portraits using multi-level omics data

Human diseases such as cancer are routinely characterized by high-throughput molecular technologies, and multi-level omics data are accumulated in public databases at increasing rate. Retrieval and visualization of these data in the context of molecular network maps can provide insights into the pattern of molecular functions encompassed by an omics profile. In order to make this task easy, we developed NaviCom, a Python package and web platform for visualization of multi-level omics data on top of biological network maps. NaviCom is bridging the gap between cBioPortal, the most used resource of large-scale cancer omics data and NaviCell, a data visualization web service that contains several molecular network map collections. NaviCom proposes several standardized modes of data display on top of molecular network maps, allowing to address specific biological questions. We illustrate how users can easily create interactive network-based cancer molecular portraits via NaviCom web interface using the maps of Atlas of Cancer Signaling Network (ACSN) and other maps. Analysis of these molecular portraits can help in formulating a scientific hypothesis on the molecular mechanisms deregulated in the studied disease.

systems biology↗